176 related articles for article (PubMed ID: 12828862)
41. Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.
Melo SP; Lisowski L; Bashkirova E; Zhen HH; Chu K; Keene DR; Marinkovich MP; Kay MA; Oro AE
Mol Ther; 2014 Apr; 22(4):725-33. PubMed ID: 24390279
[TBL] [Abstract][Full Text] [Related]
42. Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa.
Meng X; Klement JF; Leperi DA; Birk DE; Sasaki T; Timpl R; Uitto J; Pulkkinen L
J Invest Dermatol; 2003 Oct; 121(4):720-31. PubMed ID: 14632187
[TBL] [Abstract][Full Text] [Related]
43. Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.
Hammersen J; Has C; Naumann-Bartsch N; Stachel D; Kiritsi D; Söder S; Tardieu M; Metzler M; Bruckner-Tuderman L; Schneider H
J Invest Dermatol; 2016 Nov; 136(11):2150-2157. PubMed ID: 27375110
[TBL] [Abstract][Full Text] [Related]
44. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
[TBL] [Abstract][Full Text] [Related]
45. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
Jeon IK; Kim SE; Kim SC
J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
[TBL] [Abstract][Full Text] [Related]
46. A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration.
Di Zenzo G; El Hachem M; Diociaiuti A; Boldrini R; Calabresi V; Cianfarani F; Fortugno P; Piccinni E; Zambruno G; Castiglia D
Br J Dermatol; 2014 May; 170(5):1056-64. PubMed ID: 24387836
[TBL] [Abstract][Full Text] [Related]
47. LAD-1 is absent in a subset of junctional epidermolysis bullosa patients.
Marinkovich MP; Tran HH; Rao SK; Giudice GJ; Balding S; Jonkman MF; Pas HH; McGuire JS; Herron GS; Bruckner-Tuderman L
J Invest Dermatol; 1997 Sep; 109(3):356-9. PubMed ID: 9284104
[TBL] [Abstract][Full Text] [Related]
48. Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts.
Quenneville SP; Chapdelaine P; Rousseau J; Beaulieu J; Caron NJ; Skuk D; Mills P; Olivares EC; Calos MP; Tremblay JP
Mol Ther; 2004 Oct; 10(4):679-87. PubMed ID: 15451452
[TBL] [Abstract][Full Text] [Related]
49. Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.
Baudoin C; Miquel C; Blanchet-Bardon C; Gambini C; Meneguzzi G; Ortonne JP
J Clin Invest; 1994 Feb; 93(2):862-9. PubMed ID: 8113417
[TBL] [Abstract][Full Text] [Related]
50. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J
Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation.
McMillan JR; McGrath JA; Pulkkinen L; Kon A; Burgeson RE; Ortonne JP; Meneguzzi G; Uitto J; Eady RA
Br J Dermatol; 1997 Jun; 136(6):817-22. PubMed ID: 9217810
[TBL] [Abstract][Full Text] [Related]
52. Regeneration of the entire human epidermis using transgenic stem cells.
Hirsch T; Rothoeft T; Teig N; Bauer JW; Pellegrini G; De Rosa L; Scaglione D; Reichelt J; Klausegger A; Kneisz D; Romano O; Secone Seconetti A; Contin R; Enzo E; Jurman I; Carulli S; Jacobsen F; Luecke T; Lehnhardt M; Fischer M; Kueckelhaus M; Quaglino D; Morgante M; Bicciato S; Bondanza S; De Luca M
Nature; 2017 Nov; 551(7680):327-332. PubMed ID: 29144448
[TBL] [Abstract][Full Text] [Related]
53. Structural Defects of Laminin β3 N-terminus Underlie Junctional Epidermolysis Bullosa with Altered Granulation Tissue Response.
El Hachem M; Fortugno P; Palmeri A; Helmer-Citterich M; Diociaiuti A; Proto V; Boldrini R; Zambruno G; Castiglia D
Acta Derm Venereol; 2016 Nov; 96(7):954-958. PubMed ID: 27120332
[TBL] [Abstract][Full Text] [Related]
54. Herlitz junctional epidermolysis bullosa with a novel mutation in LAMB3.
Kittridge A; Patel R; Novoa R; Tamburro J
Pediatr Dermatol; 2014; 31(4):530-2. PubMed ID: 23278291
[TBL] [Abstract][Full Text] [Related]
55. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.
Posteraro P; Sorvillo S; Gagnoux-Palacios L; Angelo C; Paradisi M; Meneguzzi G; Castiglia D; Zambruno G
Biochem Biophys Res Commun; 1998 Feb; 243(3):758-64. PubMed ID: 9501007
[TBL] [Abstract][Full Text] [Related]
56. Generalized atrophic benign epidermolysis bullosa.
Darling TN; Bauer JW; Hintner H; Yancey KB
Adv Dermatol; 1997; 13():87-119; discussion 120. PubMed ID: 9551142
[TBL] [Abstract][Full Text] [Related]
57. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5).
Aberdam D; Galliano MF; Vailly J; Pulkkinen L; Bonifas J; Christiano AM; Tryggvason K; Uitto J; Epstein EH; Ortonne JP
Nat Genet; 1994 Mar; 6(3):299-304. PubMed ID: 8012394
[TBL] [Abstract][Full Text] [Related]
58. Generalized gravis junctional epidermolysis bullosa: case report, laboratory evaluation, and review of recent advances.
Lim KK; Su WP; McEvoy MT; Pittelkow MR
Mayo Clin Proc; 1996 Sep; 71(9):863-8. PubMed ID: 8790263
[TBL] [Abstract][Full Text] [Related]
59. Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.
Jiang QJ; Izakovic J; Zenker M; Fartasch M; Meneguzzi G; Rascher W; Schneider H
J Pediatr; 2002 Oct; 141(4):553-9. PubMed ID: 12378197
[TBL] [Abstract][Full Text] [Related]
60. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
